Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT02171273
The overall objectives of the proposed study are to examine the consequences of chronic circadian disruption and chronic sleep restriction on metabolic function in healthy adults.
Looking for future studies?
Notify Me21 year–70 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
It has long been recognized that sleep patterns change with age. A common feature of aging is the advance of the timing of sleep to earlier hours, often earlier than desired. These age-related changes are found in even healthy individuals who are not taking medications and who are free from sleep disorders. In addition to these sleep disturbances, many older individuals curtail their sleep voluntarily, reporting similar rates of sleep restriction (sleeping less than 7 or less than 6 hours per night) when compared to young adults. Whether voluntary or not, insufficient sleep has medical, safety and metabolic consequences. In fact, converging evidence in young adults suggests that sleep restriction per se may impair metabolism, and that reduced sleep duration is associated with weight gain, obesity, diabetes, cardiovascular disease, and mortality. An understanding of how the circadian and sleep homeostatic neurobiological processes responds to increasing homeostatic sleep pressure, and the effects of sleep restriction on metabolism at different ages, should provide information on the regulation of sleep and metabolism in aging, as well as direction for future treatments. In the present study, we will study the separate impacts of chronic sleep restriction (while minimizing circadian disruption) and chronic circadian disruption (while minimizing sleep disruption) and a poor diet on metabolism.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Following a baseline of adequate time in bed, study participants will spend 3 weeks on a daily jet-lag schedule (where each day is longer than 24 hours).
Following a baseline of adequate time in bed, study participants will have a shortened opportunity for sleep during each 24-hour day (for three weeks).
Following a baseline of adequate time in bed, study participants will continue to have adequate time in bed and opportunity for sleep during each 24-hour day, for 3 weeks.
Time frame: Baseline day 3, at 1 week and at 3 weeks of exposure, and 1 week into recovery
Euglycemic hyperinsulinemic clamp-assessed measure of insulin sensitivity
Time frame: Baseline day 2, daily throughout 1st and 3rd weeks of exposure, and 1 week into recovery
Frequent blood samples during and after standardized meal (breakfast), response of blood glucose levels
Time frame: Baseline day 2, daily throughout 1st and 3rd weeks of exposure, and 1 week into recovery
Frequent blood samples during and after standardized meal (breakfast)
Time frame: Baseline day 2, during acute circadian misalignment (exposure day 3), and acute realignment (exposure day 7)
Hourly blood samples for 24 hours
Time frame: Baseline day 2, at 3 weeks of exposure, and 1 week into recovery
Hourly blood samples for 24 hours
Time frame: Baseline days 2 and 3, daily throughout 1st and 3rd weeks of exposure, and 1 week into recovery
Indirect calorimetry, daily body weight, core body temperature
Time frame: Continuous throughout the 3-day baseline, 3-week exposure, and 1-week recovery
Via measurement of core body temperature and melatonin (salivary and plasma)
Time frame: Continuous throughout the 3-day baseline, 3-week exposure, and 1-week recovery
Polysomnography during sleep and wake
Time frame: Daily throughout the 3-day baseline, 3-week exposure, and 1-week recovery
Cognitive test battery presented via computer interface
Time frame: Daily throughout the 3-day baseline, 3-week exposure, and 1-week recovery
Daily questionnaires
Time frame: Baseline days 2 and 3, daily throughout 1st and 3rd weeks of exposure, and 1 week into recovery
Measurements on fasted blood samples
Time frame: Baseline day 2, at 1 week and at 3 weeks of exposure, and 1 week into recovery
Blood samples collected every 4 hours for 48 hours
Time frame: Baseline day 3, at 1 week and at 3 weeks of exposure, and 1 week into recovery
EKG, urinary catecholamines, fasting and postprandial blood samples for cortisol, epinephrine and norepinephrine
Time frame: Daily throughout the 3-day baseline, last 3 days of the 3-week exposure, and last three days of the 1-week recovery
Bomb calorimetry on stool samples
Brigham and Women's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03814304
Accidental Falls, Aging
Roslindale, Massachusetts, United States
View Trial DetailsNCT05866393
Aging, Behavior
Cleveland, Ohio, United States
View Trial DetailsNCT04276805
Aging
Tucson, Arizona, United States
View Trial DetailsNCT05018117
Aging
Berkeley, California, United States
View Trial Details